AU2020248020A1 - Promoter region analysis methods and cells for practicing same - Google Patents

Promoter region analysis methods and cells for practicing same Download PDF

Info

Publication number
AU2020248020A1
AU2020248020A1 AU2020248020A AU2020248020A AU2020248020A1 AU 2020248020 A1 AU2020248020 A1 AU 2020248020A1 AU 2020248020 A AU2020248020 A AU 2020248020A AU 2020248020 A AU2020248020 A AU 2020248020A AU 2020248020 A1 AU2020248020 A1 AU 2020248020A1
Authority
AU
Australia
Prior art keywords
cell
activity
promoter region
agent
carrier protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020248020A
Other languages
English (en)
Inventor
Venkatesh Chari
Jane Lamerdin
Jennifer LIN-JONES
Paul Shapiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eurofins Discoverx Products LLC
Original Assignee
Eurofins Discoverx Products LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurofins Discoverx Products LLC filed Critical Eurofins Discoverx Products LLC
Publication of AU2020248020A1 publication Critical patent/AU2020248020A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
    • G01N2333/938—Hydrolases (3) acting on glycosyl compounds (3.2) acting on beta-galactose-glycoside bonds, e.g. beta-galactosidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
AU2020248020A 2019-03-28 2020-03-26 Promoter region analysis methods and cells for practicing same Abandoned AU2020248020A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962825559P 2019-03-28 2019-03-28
US62/825,559 2019-03-28
PCT/US2020/025055 WO2020198525A1 (en) 2019-03-28 2020-03-26 Promoter region analysis methods and cells for practicing same

Publications (1)

Publication Number Publication Date
AU2020248020A1 true AU2020248020A1 (en) 2021-10-28

Family

ID=72607352

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020248020A Abandoned AU2020248020A1 (en) 2019-03-28 2020-03-26 Promoter region analysis methods and cells for practicing same

Country Status (9)

Country Link
US (1) US20200308591A1 (https=)
EP (1) EP3947714A4 (https=)
JP (1) JP2022528270A (https=)
KR (1) KR20210138766A (https=)
CN (1) CN113785072A (https=)
AU (1) AU2020248020A1 (https=)
CA (1) CA3116068A1 (https=)
IL (1) IL286671B2 (https=)
WO (1) WO2020198525A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202328452A (zh) * 2021-09-07 2023-07-16 俄羅斯聯邦商拜奧卡德聯合股份公司 誘導型啟動子、基於其的載體和宿主細胞
CN115786340B (zh) * 2022-11-04 2023-12-05 江南大学 一种提高leaderless启动子活性的方法及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0338045B1 (en) * 1987-09-21 1994-08-24 Microgenics Corporation Solid-phase non-separation enzyme assay
US5223393A (en) * 1990-06-12 1993-06-29 Microgenics Corporation Detection of analytes having binding sites for at least two binding moieties
US7062219B2 (en) * 1997-01-31 2006-06-13 Odyssey Thera Inc. Protein fragment complementation assays for high-throughput and high-content screening
CA2205888A1 (en) * 1997-07-11 1999-01-11 John J. Priatel Complementation trap
AU2217800A (en) * 1998-12-24 2000-07-31 Small Molecule Therapeutics, Inc. Methods and compositions for identifying protease modulators
WO2003065004A2 (en) * 2002-01-29 2003-08-07 Discoverx, Inc. Enzyme activation protease assay
JP4796059B2 (ja) * 2004-06-30 2011-10-19 ディスカヴァーエックス コーポレイション 細胞内修飾の分析
JP5303448B2 (ja) * 2006-03-13 2013-10-02 ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ 親和性が減少した酵素の相補性レポーター系を用いた分子相互作用の検出
US8865421B2 (en) * 2008-07-02 2014-10-21 Discoverx Corporation Assays for nuclear hormone receptor binding
WO2013119579A1 (en) * 2012-02-06 2013-08-15 Discoveryx Corporation Detection of intracellular binding events by measuring protein abundance
JP2016523088A (ja) * 2013-06-26 2016-08-08 フィロジカ リミテッドＰｈｙｌｏｇｉｃａ Ｌｉｍｉｔｅｄ ペプチドの細胞輸送をモニタリングする方法
EP3183580B1 (en) * 2014-08-21 2025-03-26 Eurofins DiscoverX Corporation Homogenous thermal shift ligand binding assay

Also Published As

Publication number Publication date
WO2020198525A1 (en) 2020-10-01
KR20210138766A (ko) 2021-11-19
US20200308591A1 (en) 2020-10-01
JP2022528270A (ja) 2022-06-09
IL286671A (en) 2021-10-31
EP3947714A4 (en) 2022-12-14
IL286671B2 (en) 2024-01-01
CN113785072A (zh) 2021-12-10
IL286671B1 (en) 2023-09-01
EP3947714A1 (en) 2022-02-09
CA3116068A1 (en) 2020-10-01

Similar Documents

Publication Publication Date Title
Remeseiro et al. Cohesin‐SA1 deficiency drives aneuploidy and tumourigenesis in mice due to impaired replication of telomeres
Gudmundsdottir et al. DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells
Kong et al. α4 is an essential regulator of PP2A phosphatase activity
Bryans et al. Absence of DNA ligase IV protein in XR-1 cells: evidence for stabilization by XRCC4
Dormoy-Raclet et al. The RNA-binding protein HuR promotes cell migration and cell invasion by stabilizing the β-actin mRNA in a U-rich-element-dependent manner
CA2285426C (en) Detection of molecular interactions by reporter subunit complementation
Ezzeddine et al. Evidence providing new insights into TOB-promoted deadenylation and supporting a link between TOB's deadenylation-enhancing and antiproliferative activities
US8541175B2 (en) Detection of molecular interactions using a reduced affinity enzyme complementation reporter system
Murray et al. H3K4me3 is neither instructive for, nor informed by, transcription
Chakraborty et al. E-cadherin differentially regulates the assembly of Connexin43 and Connexin32 into gap junctions in human squamous carcinoma cells
US20200308591A1 (en) Promoter region analysis methods and cells for practicing same
Lee Is age‐related increase of chromosome segregation errors in mammalian oocytes caused by cohesin deterioration?
Romanova et al. Implication of nucleolar protein SURF6 in ribosome biogenesis and preimplantation mouse development
Chen et al. Antagonistic actions of two human Pan3 isoforms on global mRNA turnover
US20140045194A1 (en) Monitoring protein trafficking using beta-galactosidase reporter fragment complementation
EP2810064B1 (en) Cell based sensor
Liu et al. Reversible proliferative arrest induced by rapid depletion of RNase MRP
CA2662507C (en) Detection of sub-cellular compartment localization of a molecule using a reduced affinity enzyme complementation reporter system
Takahashi et al. Fission yeast Pot1 and RecQ helicase are required for efficient chromosome segregation
Roiuk et al. Human eIF2A has a minimal role in translation initiation and in uORF-mediated translational control
Marchese Ubiquitination of chemokine receptors
Thomas et al. Synchronous chromosome segregation in mouse oocytes is ensured by biphasic securin destruction and cyclin B1-Cdk1
Savill et al. Functional structure of the promoter regions for the predominant low molecular weight isoforms of tropomyosin in human kidney cells
Tomita et al. C1D is not directly involved in the repair of UV-damaged DNA but protects cells from oxidative stress by regulating gene expressions in human cell lines
Badie et al. Impaired telomerase activity in human cells expressing GFP-Ku86 fusion proteins

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted